The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Upfront palliative resection of primary tumor versus no resection in patients with synchronous metastatic colorectal cancer: The randomized phase 3 CAIRO4 study of the Dutch Colorectal Cancer Group (DCCG).
 
Miriam Koopman
Research Funding - Bayer (Inst); BMS GmbH & Co. KG (Inst); Merck Serono (Inst); Personal Genome Diagnostics (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst)
 
Dave Eduard Wilhelm van der Kruijssen
Research Funding - Roche (Inst)
 
Sjoerd G. Elias
No Relationships to Disclose
 
Peter M. van de Ven
No Relationships to Disclose
 
Linda Mol
No Relationships to Disclose
 
Cornelis J. A. Punt
Consulting or Advisory Role - Nordic Bioscience (Inst)
 
Pieter J. Tanis
Consulting or Advisory Role - Medtronic (Inst)
Research Funding - Novus Scientific (Inst)
 
Jesper Dan Nielsen
No Relationships to Disclose
 
Mette K. Yilmaz
No Relationships to Disclose
 
Olaf Loosveld
No Relationships to Disclose
 
George P. van der Schelling
No Relationships to Disclose
 
Dareczka Wasowicz-Kemps
No Relationships to Disclose
 
Johanna M.G.H. Van Riel
No Relationships to Disclose
 
Mareille Verseveld
No Relationships to Disclose
 
Paul Hamberg
Consulting or Advisory Role - Astellas Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); MSD (Inst); Pfizer (Inst)
 
Henrik Loft Jakobsen
No Relationships to Disclose
 
Anna-Lene Fromm
No Relationships to Disclose
 
Henderik L. van Westreenen
No Relationships to Disclose
 
Jan Willem de Groot
Consulting or Advisory Role - Bristol-Myers Squibb; Pierre Fabre; SERVIER
 
Johannes H.W. de Wilt
Research Funding - Medtronic (Inst); Roche (Inst)